These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 16868004)
1. A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration. Krinner EM; Hepp J; Hoffmann P; Bruckmaier S; Petersen L; Petsch S; Parr L; Schuster I; Mangold S; Lorenczewski G; Lutterbüse P; Buziol S; Hochheim I; Volkland J; Mølhøj M; Sriskandarajah M; Strasser M; Itin C; Wolf A; Basu A; Yang K; Filpula D; Sørensen P; Kufer P; Baeuerle P; Raum T Protein Eng Des Sel; 2006 Oct; 19(10):461-70. PubMed ID: 16868004 [TBL] [Abstract][Full Text] [Related]
2. A human monoclonal IgG1 potently neutralizing the pro-inflammatory cytokine GM-CSF. Krinner EM; Raum T; Petsch S; Bruckmaier S; Schuster I; Petersen L; Cierpka R; Abebe D; Mølhøj M; Wolf A; Sørensen P; Locher M; Baeuerle PA; Hepp J Mol Immunol; 2007 Feb; 44(5):916-25. PubMed ID: 16697465 [TBL] [Abstract][Full Text] [Related]
3. In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. Steidl S; Ratsch O; Brocks B; Dürr M; Thomassen-Wolf E Mol Immunol; 2008 Nov; 46(1):135-44. PubMed ID: 18722015 [TBL] [Abstract][Full Text] [Related]
4. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting. Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757 [TBL] [Abstract][Full Text] [Related]
5. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library. Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083 [TBL] [Abstract][Full Text] [Related]
6. PEGylated murine Granulocyte-macrophage colony-stimulating factor: production, purification, and characterization. Sainathan SK; Tu L; Bishnupuri KS; Han M; Li A; Newberry RD; McDonald KG; Crimmins DL; Houchen C; Anant S; Dieckgraefe BK Protein Expr Purif; 2005 Dec; 44(2):94-103. PubMed ID: 16213750 [TBL] [Abstract][Full Text] [Related]
7. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display. Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188 [TBL] [Abstract][Full Text] [Related]
8. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand. Albrecht H; Burke PA; Natarajan A; Xiong CY; Kalicinsky M; DeNardo GL; DeNardo SJ Bioconjug Chem; 2004; 15(1):16-26. PubMed ID: 14733579 [TBL] [Abstract][Full Text] [Related]
9. Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM-CSF) with conserved biological activity. Malik F; Delgado C; Knüsli C; Irvine AE; Fisher D; Francis GE Exp Hematol; 1992 Sep; 20(8):1028-35. PubMed ID: 1505637 [TBL] [Abstract][Full Text] [Related]
10. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility. Albrecht H; Denardo GL; Denardo SJ J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921 [TBL] [Abstract][Full Text] [Related]
11. Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system. Yang J; Kanter G; Voloshin A; Michel-Reydellet N; Velkeen H; Levy R; Swartz JR Biotechnol Bioeng; 2005 Mar; 89(5):503-11. PubMed ID: 15669088 [TBL] [Abstract][Full Text] [Related]
12. Effects of PEGylated scFv antibodies against Plasmodium vivax duffy binding protein on the biological activity and stability in vitro. Kim SH; Lee YS; Hwang SY; Bae GW; Nho K; Kang SW; Kwak YG; Moon CS; Han YS; Kim TY; Kho WG J Microbiol Biotechnol; 2007 Oct; 17(10):1670-4. PubMed ID: 18156783 [TBL] [Abstract][Full Text] [Related]
13. Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins. Whittington HA; Ashworth LJ; Hawkins RE Gene Ther; 1998 Jun; 5(6):770-7. PubMed ID: 9747457 [TBL] [Abstract][Full Text] [Related]
14. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2. Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481 [TBL] [Abstract][Full Text] [Related]
15. Identification of potent human anti-IL-1RI antagonist antibodies. Fredericks ZL; Forte C; Capuano IV; Zhou H; Vanden Bos T; Carter P Protein Eng Des Sel; 2004 Jan; 17(1):95-106. PubMed ID: 14985542 [TBL] [Abstract][Full Text] [Related]
16. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein. Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122 [TBL] [Abstract][Full Text] [Related]
17. The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis. Kaspar M; Trachsel E; Neri D Cancer Res; 2007 May; 67(10):4940-8. PubMed ID: 17510424 [TBL] [Abstract][Full Text] [Related]
18. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy. Winthrop MD; DeNardo SJ; Albrecht H; Mirick GR; Kroger LA; Lamborn KR; Venclovas C; Colvin ME; Burke PA; DeNardo GL Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3845S-53S. PubMed ID: 14506182 [TBL] [Abstract][Full Text] [Related]
20. Neutralizing human anti-B-cell-activating factor of the TNF family (BAFF) scFv selected from phage antibody library. Cao P; Xia Z; Song W; Zhang S Immunol Lett; 2005 Oct; 101(1):87-94. PubMed ID: 15939481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]